7 Geographic Atrophy Clinical Trials in Minneapolis, MN (2026)

Q: How do I join a clinical trial in Minneapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you.

Recruiting Geographic Atrophy Studies in Minneapolis

NCT06731478Recruiting

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

This clinical trial is designed to assess the efficacy and safety of the triplet combination of trastuzumab deruxtecan (ENHERTU, T-DXd, DS-8201a) plus a fluoropyrimidine plus pembrolizumab versus stan...

Minneapolis, MNPHASE3726 participantsDaiichi Sankyo

View Study Details

NCT07541573Recruiting

GTB-5550 in Advanced Solid Tumors

This is a first-in-human Phase 1a/1b trial of a B7-H3-targeted natural killer (NK) cell engager, referred to as a TriSpecific Killer Engager (TriKE), for the treatment of select solid tumor cancers. T...

Minneapolis, MNPHASE1175 participantsMasonic Cancer Center, University of Minnesota

View Study Details

NCT07223944Recruiting

A Gaucher Disease Gene Therapy Trial With FLT201

This study is a Phase 3, non-randomized, multicenter, efficacy and safety study in adult patients with Gaucher disease Type 1, on stable treatment with enzyme replacement therapy (ERT) or substrate re...

Minneapolis, MNPHASE345 participantsSpur Therapeutics

View Study Details

NCT06848205Recruiting

Percept Transitions in FOG and PD

The purpose of this research is to examine the possible causes and signs of freezing of gait (FOG) secondary to Parkinson's disease (PD). To achieve this, the study will use the novel (on-label and FD...

Minneapolis, MNNA36 participantsUniversity of Minnesota

View Study Details

NCT02437396Recruiting

Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease

The objective of this study is to evaluate oxidative stress and/or inflammation in patients with Gaucher disease type I using a series of biomarkers and correlate with measurements of currently used d...

Minneapolis, MN34 participantsUniversity of Minnesota

View Study Details

NCT05843552Recruiting

Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease

This is an observational study intended to generate preliminary data to understand how lysosomal dysfunction can affect the biogenesis of extracellular vesicles, its content and function. The primary ...

Minneapolis, MN30 participantsUniversity of Minnesota

View Study Details

NCT05586243Recruiting

MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)

Recent studies have has shown that magnetic resonance spectroscopy (MRS) can provide validated neuronal markers in patients with Type 1 GD (GD1) who are on stable therapy. However, alterations in neur...

Minneapolis, MN5 participantsUniversity of Minnesota

View Study Details

About Geographic Atrophy Clinical Trials in Minneapolis

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 7 geographic atrophy clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 1,051 participants. Research is being sponsored by Daiichi Sankyo, Masonic Cancer Center, University of Minnesota, Spur Therapeutics and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Minneapolis — FAQ

Are there geographic atrophy clinical trials in Minneapolis?

Yes, there are 7 geographic atrophy clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Minneapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.

Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 7 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated October 17, 2026 from ClinicalTrials.gov